SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-008751
Filing Date
2024-03-20
Accepted
2024-03-20 20:10:15
Documents
1
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 9066
  Complete submission text file 0001437749-24-008751.txt   10835
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXART, INC. 170 HARBOR WAY, STE. 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Lee Phillip E (Reporting) CIK: 0001959565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 24769161